Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis
Article in Clinical Pharmacology in Drug Development (January 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022
Article in Journal of the European Academy of Dermatology and Venereology (December 2023)
Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper Extremities.
Article in The Journal of clinical and aesthetic dermatology (December 2023)